(Q44648725)

5 December 2017

title

Inflammation-induced vasoconstrictor hyporeactivity is caused by oxidative stress (English)

1 reference

5 December 2017

Inflammation-induced vasoconstrictorhyporeactivity is caused by oxidative stress (English)

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Cardiology and cardiovascular medicine

30 March 2024

main subject

inflammation

0 references

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

30 March 2024

6

Michael Wolzt

1 reference

5 December 2017

Johannes Pleiner

1

1 reference

5 December 2017

Friedrich Mittermayer

2

1 reference

5 December 2017

Georg Schaller

3

1 reference

5 December 2017

Claudia Marsik

4

1 reference

5 December 2017

Raymond J. MacAllister

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14607455

30 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

5 December 2017

5 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14607455

full work available at URL

30 March 2024

https://doi.org/10.1016/j.jacc.2003.06.002

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14607455

https://api.elsevier.com/content/article/PII:S0735109703010763?httpAccept=text/xml

30 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

https://api.elsevier.com/content/article/PII:S0735109703010763?httpAccept=text/plain

30 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Journal of the American College of Cardiology

30 March 2024

published in

1 reference

5 December 2017

volume

42

1 reference

5 December 2017

issue

9

1 reference

5 December 2017

page(s)

1656-1662

1 reference

Efficacy and safety of recombinant human activated protein C for severe sepsis

5 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Adrenoceptor hyporeactivity is responsible for Escherichia coli endotoxin-induced acute vascular dysfunction in humans

30 March 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock

30 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects

30 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Heparin blunts endotoxin-induced coagulation activation

30 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

An Electrically Calibrated Plethysmograph for Direct Measurement of Limb Blood Flow

30 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Measuring forearm blood flow and interpreting the responses to drugs and mediators.

30 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

High doses of vitamin C reverse Escherichia coli endotoxin-induced hyporeactivity to acetylcholine in the human forearm

30 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus

30 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment

30 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Compartmentalised inducible nitric-oxide synthase activity in septic shock.

30 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Severe septic shock unresponsive to noradrenaline

30 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Administration of angiotensin II in refractory septic shock

30 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock

30 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Terlipressin for norepinephrine-resistant septic shock

30 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study

30 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Downregulation of angiotensin II type 1 receptors during sepsis

30 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Impaired microvascular vasoconstrictive responses to vasopressin in septic rats

30 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock.

30 March 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Induction of nitric oxide synthase and dual effects of nitric oxide and cyclooxygenase products in regulation of arterial contraction in human septic shock

30 March 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Local venous responses to endotoxin in humans

30 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Ascorbate Prevents the Interaction of Superoxide and Nitric Oxide Only at Very High Physiological Concentrations

30 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Ascorbic acid modulates in vitro the function of macrophages from mice with endotoxic shock

30 March 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Chemical modifications of the vasoconstrictor peptide angiotensin II by nitrogen oxides (NO, HNO2, HOONO)--evaluation by mass spectrometry

30 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Nitration of angiotensin II by .NO2 radicals and peroxynitrite. .NO protects against .NO2 radical reaction

30 March 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Protection against peroxynitrite-dependent tyrosine nitration and alpha 1-antiproteinase inactivation by ascorbic acid. A comparison with other biological antioxidants

30 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Ascorbate is a potent antioxidant against peroxynitrite-induced oxidation reactions. Evidence that ascorbate acts by re-reducing substrate radicals produced by peroxynitrite

30 March 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Biphasic forearm vascular responses to intraarterial arginine vasopressin

30 March 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

Endotoxin tolerance: a review

30 March 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2003.06.002

30 March 2024

Identifiers

1 reference

5 December 2017

1 reference